정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 282 | Not yet recruiting | The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial) | Covid19 | Drug: Ivermectin 0.6mg/kg/day Drug: Ivermectin 1.0mg/kg/day Drug: Placebo Drug: Hydroxychloroquine |
Phase 3 | Corpometria Institute | OTHER | 294 | All | 18 Years | |
| 281 | Recruiting | The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients | Covid-19 | Drug: Resveratrol Drug: Placebo capsules |
Not Applicable | Hong Kong Baptist University, Hospital Authority, Hong Kong | OTHER | 30 | All | 18 Years ~ 65 Years | Linda Zhong, Kowloon Tong, Kowloon, Hong Kong |
| 280 | Recruiting | The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) | COVID-19 Vaccines | Biological: ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine Other: Placebo (normal saline) |
Phase 3 | Vinbiocare Biotechnology Joint Stock Company, Arcturus Therapeutics, Inc. | INDUSTRY | 21000 | All | 18 Years ~ 100 Years | Pasteur Institute, Ho Chi Minh City, Ho Chi Minh, Vietnam Hanoi Medical University, Ha Noi, Vietnam Military Medical University, Ha Noi, Vietnam |
| 279 | Not yet recruiting | The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19 | Acute Respiratory Distress | Drug: Adenosine | Phase 2 | University of Florida | OTHER | 30 | All | 18 Years ~ 105 Years | |
| 278 | Active, not recruiting | The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions | Bioequivalence | Drug: ATAFENOVIR 200 MG KAPSUL Drug: ARBIDOL 100 MG KAPSUL |
Phase 1 | Atabay Kimya Sanayi Ticaret A.S., Novagenix Bioanalytical Drug R&D Center, Farmagen Ar-Ge Biyot. Ltd. Sti | INDUSTRY | 18 | Male | 20 Years ~ 40 Years | Novagenix Drug R&D Center, Akyurt, Ankara, Turkey Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey |
| 277 | Not yet recruiting | The Clinical Study of Carrimycin on Treatment Patients With COVID-19 | Novel Coronavirus Infectious Disease (COVID-19) | Drug: Carrimycin Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate Drug: basic treatment |
Phase 4 | Beijing YouAn Hospital, Shenyang Tonglian Group CO., Ltd, Chinese Academy of Medical Sciences, Huangshi Central Hospital, China, Shenyang Pharmaceutical University, First Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Harbin Medical University, No.2 People's Hospital of Fuyang City, First Affiliated Hospital Bengbu Medical College, Renmin Hospital of Wuhan University, The Sixth People's Hospital of Shenyang, Nanyang Central Hospital | OTHER | 520 | All | 18 Years ~ 75 Years | |
| 276 | Completed | The Containing Coronavirus Disease 19 (COVID-19) Trial | Covid19 | Biological: Peginterferon beta-1a | Phase 3 | Pontificia Universidad Catolica de Chile, Telethon Kids Institute | OTHER | 1173 | All | 18 Years ~ 79 Years | Pontificia Universidad Catolica de Chile, Santiago, Chile |